Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × Leucovorin × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 35 Pancreatic Neoplasms 15 Stomach Neoplasms 14 Colonic Neoplasms 10 Rectal Neoplasms 9 Neoplasm Metastasis 9 Esophageal Neoplasms 8 Adenocarcinoma Of Esophagus 8 Neoplasms 7 Cholangiocarcinoma 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 7 Biliary Tract Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia 2 Gallbladder Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Carcinoma, Renal Cell 2

Interventions

capivasertib 2 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 copanlisib 1 axicabtagene ciloleucel 1 Receptors, Interleukin-6 1 Interleukin 1 Receptor Antagonist Protein 1 Fulvestrant 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡